Solvigen GmbH, headquartered in Berlin, Germany, is an innovation and investment firm dedicated to scaling transformative healthcare technologies for global impact. As a trusted Indo-German bridge, we specialize in the development, acquisition, and globalization of solutions in MedTech, Digital Therapeutics, Biotechnology & Pharmaceuticals, Wearable Technologies, Functional Beverages, and Healthcare Mobility, while also exploring strategic sectors like Renewables, EVs, Semiconductors, and Agritech. Through our Global Trade & Investment Division, we empower German Mittelstand and SMEs to expand into high-growth markets via FDI, joint ventures, manufacturing, R&D collaborations, and technology transfer—fully aligned with Make in India and Viksit Bharat 2047. We identify emerging innovations, foster strategic partnerships with startups, research institutions, and industry leaders, and provide market research, strategy development, and ecosystem support to accelerate scalable, sustainable growth. Recognized by Hon’ble Minister Shri Piyush Goyal for our engagement with German industry and collaboration with the Ministry of Commerce & Industry, Solvigen is driving Indo-German bilateral trade, fostering innovation and technology exports, and promoting excellence across industries. Let’s collaborate to shape a healthier, more innovative world.
As the Founder and CEO of Solvigen GmbH, I am dedicated to monetizing cutting-edge healthcare innovations and scaling them globally. At Solvigen, we bridge the gap between groundbreaking technologies and the global healthcare market, driving success through strategic partnerships and market expansion.
Our focus is on turning transformative ideas into thriving businesses, leveraging both innovation acquisition and globalization to maximize impact. We collaborate with global innovators, startups, and research institutions, enabling them to scale and achieve success worldwide.
Let’s connect and explore how we can create a future where innovation thrives and healthcare excellence is accessible across borders.